The principal aim of the research program set forth in this application is to improve the synthetic methodology currently used to synthesize compounds with anticancer activity. In particular the stereoselectivity of the synthetic reactions is of major concern. Some examples of active compounds are the terpenoids; phyllanthoside, which has demonstrated activity against the NCI murine B16 melanoma as well as some life extension against the PS leukemia cell line, and taxol, which has demonstrated activity against the B16 melanoma as well as the colon CX-1 adenocarcinoma xenograft and the MX-1 mammary carcinoma xenograft. While the source of these compounds is from plant extracts, a suitable synthetic route would be preferable| The work outlined herein will greatly assist with the ongoing development of synthetic routes to the compounds mentioned above as well as offer the possibility for improvement in the synthetic routes to the tetracyclane antitumor antibiotics in the daunomycin family and the novel spirocyclic antitumor compound fredericamycin. The overall, long range goal of this work remains to explain the reactivity of the most common and useful organic nucleophiles and to predict with certainty the stereochemistry of the important synthetic reactions in which these species are used. The substrates under study are the primary reagents in the construction of architecturally complex organic molecules such as the terpenoid tumor promoters and inhibitors and especially the macrolide antibiotics. Positive results from this investigation will permit a more rational choice of reagents for the asymmetric synthesis of the physiologically active organic molecules.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Modified Research Career Development Award (K04)
Project #
5K04CA001330-03
Application #
3071842
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1988-07-01
Project End
1993-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Brown University
Department
Type
Schools of Arts and Sciences
DUNS #
001785542
City
Providence
State
RI
Country
United States
Zip Code
02912
Kim, Ryung S (2015) A new comparison of nested case-control and case-cohort designs and methods. Eur J Epidemiol 30:197-207
Kim, Ryung S; Kaplan, Robert C (2014) Analysis of secondary outcomes in nested case-control study designs. Stat Med 33:4215-26
Wengerter, Brian C; Katakowski, Joseph A; Rosenberg, Jacob M et al. (2014) Aptamer-targeted antigen delivery. Mol Ther 22:1375-1387
Nevadunsky, Nicole S; Van Arsdale, Anne; Strickler, Howard D et al. (2014) Metformin use and endometrial cancer survival. Gynecol Oncol 132:236-40
Giambra, Vincenzo; Volpi, Sabrina; Emelyanov, Alexander V et al. (2008) Pax5 and linker histone H1 coordinate DNA methylation and histone modifications in the 3'regulatory region of the immunoglobulin heavy chain locus. Mol Cell Biol 28:6123-33
Sepulveda, Manuel A; Garrett, Francine E; Price-Whelan, Alexa et al. (2005) Comparative analysis of human and mouse 3' Igh regulatory regions identifies distinctive structural features. Mol Immunol 42:605-15
Sepulveda, Manuel A; Emelyanov, Alexander V; Birshtein, Barbara K (2004) NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. J Immunol 172:1054-64
Yang, WanCai; Bancroft, Laura; Nicholas, Courtney et al. (2003) Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk diet. Cancer Res 63:4990-6
Van Nguyen, Andrew; Pollard, Jeffrey W (2002) Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. Dev Biol 247:11-25
Nguyen, A V; Pollard, J W (2000) Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development 127:3107-18

Showing the most recent 10 out of 102 publications